ANVS Stock: Annovis Bio, Inc. Stock Price, Analysis & Insights
Get live anvs stock price $3.15, comprehensive Annovis Bio, Inc. stock analysis, charts, news, and expert forecast. Real-time anvs stock data and investment insights.
Loading chart...
Company Overview
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead compound is Buntanetap, an orally administered drug, which has completed Phase 2a clinical trials for the treatment of Alzheimer's disease (AD) and Parkinson's disease, as well as is in clinical trials for Alzheimer's disease in Down Syndrome and other chronic neurodegenerative disorders. It is also developing ANVS405 for protecting the traumatic brain injury and stroke; and ANVS301, which is in Phase I clinical trials to increase cognitive capability in later stages of AD and dementia. The company was incorporated in 2008 and is based in Berwyn, Pennsylvania.
Company Information
- CEO
- Maria L. Maccecchini
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 8
Contact Information
- Website
- https://www.annovisbio.com
- Address
- 1055 Westlakes Drive
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Higher growth potential with elevated volatility (Beta: 1.61)
Business Model & Strategy
Annovis Bio, Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Maria L. Maccecchini, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Annovis Bio, Inc. competes in the Biotechnology within the broader Healthcare. With 62.0 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the New York Stock Exchange, Annovis Bio, Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Annovis Bio, Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Annovis Bio, Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Annovis Bio, Inc.
- ⚠Investors should consider how Annovis Bio, Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
61.99M
P/E Ratio
-2.20
Beta
1.61
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 61.99M market capitalization
- Trading Volume: 2.09M shares traded today
- Price Range: 52-week range of $1.11 - $7.52
- Exchange: Listed on New York Stock Exchange
Financial Metrics
Market Analysis for Annovis Bio, Inc.
Annovis Bio, Inc. (ANVS) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 61.99M, the company represents a significant player in its market. The stock is currently trading at $3.15 with a positivedaily change of 3.98%.
The company's 8 employee base and presence on the New York Stock Exchangeexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -2.20, beta of 1.61, and 52-week price range from $1.11 to $7.52when evaluating investment opportunities.
Why Invest in Annovis Bio, Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (New York Stock Exchange)
- • Experienced leadership under Maria L. Maccecchini
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.